Why the FDA’s push for real-time clinical trials could favor Big Pharma
The agency's new initiative promises faster drug approval times, but smaller trial sponsors could struggle to keep up.
The agency's new initiative promises faster drug approval times, but smaller trial sponsors could struggle to keep up.